17-7436034-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178518.3(TMEM102):āc.163A>Cā(p.Lys55Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,326 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178518.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM102 | NM_178518.3 | c.163A>C | p.Lys55Gln | missense_variant | 2/3 | ENST00000323206.2 | NP_848613.1 | |
TMEM102 | NM_001320444.1 | c.163A>C | p.Lys55Gln | missense_variant | 1/2 | NP_001307373.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM102 | ENST00000323206.2 | c.163A>C | p.Lys55Gln | missense_variant | 2/3 | 1 | NM_178518.3 | ENSP00000315387 | P1 | |
TMEM102 | ENST00000396568.1 | c.163A>C | p.Lys55Gln | missense_variant | 1/2 | 2 | ENSP00000379815 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249634Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135426
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461326Hom.: 1 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726978
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.163A>C (p.K55Q) alteration is located in exon 2 (coding exon 1) of the TMEM102 gene. This alteration results from a A to C substitution at nucleotide position 163, causing the lysine (K) at amino acid position 55 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at